Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of Adverse Pregnancy Outcomes at Advanced Maternal Age

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Chance of live birth: a nationwide, registry-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association between women's age and stage, morphology, and implantation of the competent blastocyst: a multicenter cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Identification of a unique epigenetic profile in women with diminished ovarian reserve

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Vitamin D levels and the risk of prostate cancer and prostate cancer mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: To investigate the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in parturient women, their partners, and their newborns and the association of such antibodies with obstetric and neonatal outcomes.

METHODS: From April 4 to July 3, 2020, in a single university hospital in Denmark, all parturient women and their partners were invited to participate in the study, along with their newborns. Participating women and partners had a pharyngeal swab and a blood sample taken at admission; immediately after delivery, a blood sample was drawn from the umbilical cord. The swabs were analyzed for SARS-CoV-2 RNA by polymerase chain reaction, and the blood samples were analyzed for SARS-CoV-2 antibodies. Full medical history and obstetric and neonatal information were available.

RESULTS: A total of 1,313 parturient women (72.5.% of all women admitted for delivery at the hospital in the study period), 1,188 partners, and 1,206 newborns participated in the study. The adjusted serologic prevalence was 2.6% in women and 3.5% in partners. Seventeen newborns had SARS-CoV-2 immunoglobulin G (IgG) antibodies, and none had immunoglobulin M antibodies. No associations between SARS-CoV-2 antibodies and obstetric or neonatal complications were found (eg, preterm birth, preeclampsia, cesarean delivery, Apgar score, low birth weight, umbilical arterial pH, need for continuous positive airway pressure, or neonatal admission), but statistical power to detect such differences was low. Full serologic data from 1,051 families showed an absolute risk of maternal infection of 39% if the partner had antibodies.

CONCLUSION: We found no association between SARS-CoV-2 infection and obstetric or neonatal complications. Sixty-seven percent of newborns delivered by mothers with antibodies had SARS-CoV-2 IgG antibodies. A limitation of our study is that we lacked statistical power to detect small but potentially meaningful differences between those with and without evidence of infection.

Original languageEnglish
JournalObstetrics and Gynecology
Volume137
Issue number1
Pages (from-to)49-55
Number of pages7
ISSN0029-7844
DOIs
Publication statusPublished - 1 Jan 2021

Bibliographical note

Copyright © 2020 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

    Research areas

  • Adult, Antibodies, Viral/blood, COVID-19 Testing/statistics & numerical data, COVID-19/blood, Denmark/epidemiology, Female, Hospitalization, Hospitals, University, Humans, Immunoglobulin G/blood, Immunoglobulin M/blood, Infant, Newborn/blood, Infectious Disease Transmission, Vertical/statistics & numerical data, Male, Obstetric Labor Complications/epidemiology, Pregnancy, Pregnancy Complications, Infectious/epidemiology, Pregnancy Outcome/epidemiology, Premature Birth/epidemiology, Regression Analysis, Risk Factors, SARS-CoV-2/immunology, Sexual Partners

ID: 61406066